Recommendations for the Treatment of Hypertension in Patients with DM: Critical Evaluation Based on Clinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|1|1|21-33

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.1, Iss.1, 2006-01, pp. : 21-33

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma

By S H.   J B.   K C.   H B.   R P.   L F.   K R.   M D.   N S.   F C.   J R.  

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 3, 2002-06 ,pp. : 115-127

Adis International

Access to resources Recommend Favorite

Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment

By Reboldi Gianpaolo   Gentile Giorgio   Angeli Fabio   Verdecchia Paolo  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 1, 2011-01 ,pp. : 115-128

Informa Healthcare

Access to resources Recommend Favorite

Rilmenidine useful for the treatment of hypertension in DM

By  

Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Ongoing clinical trials in systemic hypertension

By Oddou Pascale   Mann Jessica  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 11, 2001-11 ,pp. : 2031-2037

Informa Healthcare

Access to resources Recommend Favorite

Inclusion of Patients with Severe Mental Illness in Clinical Trials: Issues and Recommendations Surrounding Informed Consent

By Welie Sander P.K.   Berghmans Ron L.P.  

CNS Drugs, Vol. 20, Iss. 1, 2006-01 ,pp. : 67-83

Adis International

Access to resources Recommend Favorite